Addus HomeCare (NASDAQ:ADUS) Reports Q2 CY2026 In Line With Expectations
Addus HomeCare (NASDAQ: ADUS) reported Q2 CY2026 results. Revenue rose 8% year on year to $377.4 million, matching Wall Street expectations. Non-GAAP adjusted EPS was $1.73, up from $1.49 a year earlier and 1.9% above consensus. Analysts expect full-year EPS to rise from $6.68 to $7.20.
How this was made
The 30-second read
Why it matters
Q2 results were described as in line on revenue but slightly ahead on adjusted EPS, with margins stable; the market reaction was negative and the forward revenue growth outlook was projected to decelerate.
Market read
Traders can use the reported revenue/EPS and the stated deceleration in expected revenue growth to reassess near-term valuation and earnings trajectory.
What to watch
Average billable patients rose to 51,097 while revenue grew slower, implying pricing pressure; traders may focus on whether that trend reverses in subsequent quarters.
Background
Addus HomeCare serves about 66,000 clients across 22 states, focused on dual-eligible Medicare and Medicaid beneficiaries.
Ticker impact
Addus HomeCare reported Q2 CY2026 revenue of $377.4M (+8% YoY) and adjusted EPS of $1.73, beating consensus by 1.9%.
Near-term volatility likely persists; follow-through depends on whether investors re-rate the decelerating revenue outlook and patient mix.
The article provides hard earnings datapoints (revenue, EPS, margin stability) plus a same-article price reaction (down 2.6%), and notes analyst expectations for revenue growth to slow to 5.4% over 12 months.
Market effects
Home healthcare demand appears resilient but the cited 12-month revenue growth deceleration may temper sector multiple expectations.
No specific regional read-through beyond the company’s 22-state footprint.
Limited, as this is company-specific earnings with no cross-border catalyst described.
Counterpoint
The EPS beat and stable adjusted operating margin (11.5%) could indicate quality earnings; the selloff may reflect positioning rather than deteriorating fundamentals.
Key entities
- companyAddus HomeCare
Home healthcare provider reporting Q2 CY2026 revenue, adjusted EPS, margins, and patient metrics.
- market_expectationWall Street consensus
Analysts’ revenue and EPS expectations referenced for the beat/in-line assessment.
